id: NEW:autism_spectrum_disorder_to_NEW:psychiatric_comorbidity_children_adolescents
name: Autism Spectrum Disorder â†’ Psychiatric Comorbidity in Children and Adolescents
from_node:
  node_id: NEW:autism_spectrum_disorder
  node_name: Autism Spectrum Disorder
to_node:
  node_id: NEW:psychiatric_comorbidity_children_adolescents
  node_name: Psychiatric Comorbidity in Children and Adolescents
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: Autism spectrum disorder (ASD) involves atypical neurodevelopmental trajectories
  affecting brain structure, connectivity, and neurotransmitter systems'
- 'Step 2: These neurobiological differences create vulnerability to dysregulation
  in emotion processing, attention, arousal, and social cognition systems'
- 'Step 3: Shared genetic and neurobiological substrates between ASD and other psychiatric
  conditions (e.g., ADHD, anxiety, intellectual disability) increase susceptibility
  to multiple disorders'
- 'Step 4: Environmental stressors including social challenges, sensory overload,
  and difficulties with daily functioning compound biological vulnerabilities'
- 'Step 5: This results in significantly elevated rates of psychiatric comorbidity
  including ADHD (26.2%), intellectual disability (22.9%), sleep disorders (19.7%),
  and anxiety disorders (11.1%)'
evidence:
  quality_rating: A
  n_studies: 39
  primary_citation: 'T. Mutluer et al. 2022. Population-Based Psychiatric Comorbidity
    in Children and Adolescents With Autism Spectrum Disorder: A Meta-Analysis. Frontiers
    in Psychiatry.'
  supporting_citations: []
description: Children and adolescents with autism spectrum disorder demonstrate substantially
  elevated rates of psychiatric comorbidity across multiple disorder categories. Population-based
  meta-analysis of 39 studies found prevalence estimates of 26.2% for ADHD, 22.9%
  for intellectual disability, 19.7% for sleep disorders, 11.1% for anxiety disorders,
  7% for disruptive disorders, 2.7% for depression, 2% for bipolar disorders, 1.8%
  for OCD, and 0.6% for psychosis. These associations reflect shared neurobiological
  substrates and genetic factors, though rates are notably lower in population-based
  samples than clinical samples.
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
quantitative_effects:
  effect_size:
    value: 26.2
    type: prevalence_percent
    ci_lower: 22.0
    ci_upper: 31.0
  p_value: null
  sample_size: null
moderators:
- name: Study setting (clinical vs population-based)
  direction: strengthens
  strength: strong
  description: Clinical and referred samples show higher psychiatric comorbidity rates
    compared to population-based studies due to referral bias
- name: Diagnostic methods
  direction: strengthens
  strength: moderate
  description: Diagnostic methods used affect estimated prevalence rates of comorbid
    conditions
- name: Index subject characteristics
  direction: strengthens
  strength: moderate
  description: Individual characteristics of study participants influence comorbidity
    prevalence estimates
